Denosumab: A cost-effective alternative for older men with osteoporosis from a Swedish payer perspective
Parthan, A, Kruse, M, Agodoa, I, Silverman, S, Orwoll, E
Published in Bone (New York, N.Y.) (01.02.2014)
Published in Bone (New York, N.Y.) (01.02.2014)
Get full text
Journal Article
Cost-Effectiveness of Primary Prophylaxis With Pegfilgrastim Vs Lipegfilgrastim To Reduce The Incidence of Febrile Neutropenia In Patients With Early Stage Breast Cancer or Non-Hodgkin Lymphoma
Fust, K, Li, X, Maschio, M, Villa, G, Parthan, A, Barron, R, Weinstein, M.C, Somers, L, Hoefkens, C, Lyman, G.H
Published in Value in health (01.05.2015)
Published in Value in health (01.05.2015)
Get full text
Journal Article
Is Denosumab Cost-Effective Compared To Oral Bisphosphonates For The Treatment Of Male Osteoporosis (Mop) In Sweden?
Parthan, A, Kruse, M.M, Agodoa, I, Tao, C.Y, Silverman, S.L, Orwoll, E
Published in Value in health (01.05.2013)
Published in Value in health (01.05.2013)
Get full text
Journal Article
PMS40 Cost-Effectiveness of Denosumab for the Treatment of Male Osteoporosis (MOP) in the Elderly in Sweden
Parthan, A, Deflin, M.M, Agodoa, I, Tao, C.Y, Silverman, S.L, Orwoll, E
Published in Value in health (01.11.2012)
Published in Value in health (01.11.2012)
Get full text
Journal Article
PCN27 Clinical Benefit and Economic Impact of Three-Years of Adjuvant Imatinib in KIT+ Gastrointestinal Stromal Tumors (GIST)
Sanon, M, Parthan, A, Taylor, D.C, Coombs, J, Paolantonio, M, Sasane, M
Published in Value in health (01.06.2012)
Published in Value in health (01.06.2012)
Get full text
Journal Article
Cost-Effectiveness Of Prophylaxis Treatment Strategies For Febrile Neutropenia In Recurrent Ovarian Cancer Patients
Fust, K, Li, X, Maschio, M, Barron, R, Weinstein, M.C, Parthan, A, Walli-Attaei, M, Chandler, D.B, Lyman, G.H
Published in Value in health (01.05.2013)
Published in Value in health (01.05.2013)
Get full text
Journal Article
PMD21 IS CYBERKNIFE A COST-EFFECTIVE OPTION FOR TREATING PROSTATE CANCER?
Parthan, A, Pruttivarasin, N, Taylor, D, Davies, D, Yang, G, Pawar, V, Weinstein, M
Published in Value in health (2011)
Published in Value in health (2011)
Get full text
Journal Article
PMH72 HEALTHCARE RESOURCE UTILIZATION (HRU) ASSOCIATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) COMPARED WITH OTHER TREATMENTS IN PUBLICLY INSURED PATIENTS WITH OPIOID USE DISORDER (OUD)
Haider, B.A., Parthan, A., Liu, J., Niu, X., Li-McLeod, J., Fratantonio, J., O'Sullivan, A.K.
Published in Value in health (01.05.2020)
Published in Value in health (01.05.2020)
Get full text
Journal Article
PNS225 A UNIFIED ANALYSIS AND MODELING FRAMEWORK FOR THE DESIGN OF OUTCOMES-BASED RISK-SHARING AGREEMENTS
Ou, W., Parthan, A., Chen, X., Pratt, W.S., Fust, K., Halpern, R., van Bavel, J., Kruse, M.
Published in Value in health (01.05.2019)
Published in Value in health (01.05.2019)
Get full text
Journal Article
PCN84 - Cost-Effectiveness of Primary Prophylaxis With Pegfilgrastim Vs Lipegfilgrastim To Reduce The Incidence of Febrile Neutropenia In Patients With Early Stage Breast Cancer or Non-Hodgkin Lymphoma
Fust, K., Li, X., Maschio, M., Villa, G., Parthan, A., Barron, R., Weinstein, M.C., Somers, L., Hoefkens, C., Lyman, G.H.
Published in Value in health (01.05.2015)
Published in Value in health (01.05.2015)
Get full text
Journal Article
CyberKnife for prostate cancer: Is it cost-effective?
Parthan, A., Pruttivarasin, N., Taylor, D., Davies, D., Yang, G., Pawar, V., Weinstein, M. C.
Published in Journal of clinical oncology (01.03.2011)
Published in Journal of clinical oncology (01.03.2011)
Get full text
Journal Article
PCN70 - Cost-Effectiveness Of Prophylaxis Treatment Strategies For Febrile Neutropenia In Recurrent Ovarian Cancer Patients
Fust, K., Li, X., Maschio, M., Barron, R., Weinstein, M.C., Parthan, A., Walli-Attaei, M., Chandler, D.B., Lyman, G.H.
Published in Value in health (01.05.2013)
Published in Value in health (01.05.2013)
Get full text
Journal Article
Health care resource use (HRU) with nonplatinum chemotherapy for previously treated advanced ovarian cancer (aOC): Findings from SEER-Medicare data
Parthan, A., Gao, S. K., Oglesby, A., Teitelbaum, A. H., Song, R., Langeberg, W. J., Borker, R.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article